Gold Pressed Latinum (CURRENCY:GPL) traded 2.2% lower against the dollar during the 1 day period ending at 17:00 PM E.T. on May 13th. In the last seven days, Gold Pressed Latinum has traded down 13.3% against the dollar. Gold Pressed Latinum has a total market cap of $67,024.00 and approximately
Listed on the Thai Stock Exchange and also traded over the US OTC markets via ADRs (OTCPK:BLJZY), Berli Jucker (BJC) is a leading integrated Thai retailer with operating presence across various countries in Southeast Asia.
Retirees should generally invest in companies with wide moats and solid dividends. In a previous article, I noted that AT&T and Unilever were easy-to-understand companies that were ideal for most retirement portfolios. Today, I’ll add two more companies to that list — alcoholic beverage giants Diageo (NYSE:DEO) and Anheuser-Busch InBev (NYSE:BUD).
This investment has everything. It offers high dividends along with terrific potential for growth. It focuses on long-term value, yet still offers the opportunity for short-term gains. It's profiting from sectors as popular as gold and energy, and as uncommon as Brazilian bonds and Iraqi oil drillers. What am I talking about? Let me explain… It's the Stansberry....More>>>
It’s apparent that Chevron (NYSE:CVX) has decided to forego its past practice of exploring for and developing giant projects over the next several years, as it focuses on accelerating production with its shale assets, which now includes about 2 million Permian acres with over 9 billion barrels of oil.
Chevron is counting on quickly ramping up production....More>>>
Solar stocks were on fire Thursday after Sunrun Inc (NASDAQ:RUN) reported earnings and California mandated solar on all new homes. Sunrun jumped as much as 19.7% while Vivint Solar Inc (NYSE:VSLR), Enphase Energy Inc (NASDAQ:ENPH), and SolarEdge Technologies Inc (NASDAQ:SEDG) were up 12.5%, 15.6%, and 16.3% respectively at their highs for the day.
United Parcel Service (NYSE:UPS) has had a rough quarter with its share price tumbling nearly 25%. The price decline associated with UPS was a result of an Amazon (NASDAQ:AMZN) announcement to launch their own package delivery service. While Amazon clearly caters to a massive customer base, I still believe UPS has a handful of qualitative aspects, as well as a relatively attractive....More>>>
President and CEO of Broadcom Ltd (NASDAQ:AVGO) Hock E Tan sold 20,000 shares of AVGO on 01/16/2018 at an average price of $265.21 a share. The total sale was $5.3 million.
Broadcom Ltd is engaged in designing, developing and supplying analog and digital semiconductor connectivity solutions. Its product portfolio serves wired infrastructure, wireless communications, enterprise storage and....More>>>
It can be hard to find great marijuana dividend stocks.
Medical marijuana was first legalized less than 20 years ago in California, so most cannabis companies haven’t been established long enough to make a profit, let alone pay a portion of their profits to shareholders in the form of dividends.
However, investors looking for marijuana stocks with dividends have another....More>>>
In January, 2000, we initiated The Lucky 13 portfolio to assist subscribers in establishing a foundation for their investment portfolios, observes dividend expert Kelley Wright, editor of Investment Quality Trends.
For the fifteenth time in its seventeen-year history, The Lucky 13 portfolio realized a positive total return with a gain of 16.30%.
The Cheesecake Factory (CAKE) has been challenged in 2017 to maintain its multi-year winning streak of uninterrupted growth in terms of both comparable sales and operating profits. As with other casual dining chains and the restaurant industry overall, the company continues to face headwinds on both the demand and the cost sides of the equation.
Yet even as challenging industry dynamics....More>>>
Eni (E) is an Italian multinational oil and gas company headquartered in Rome. With a $60 billion market cap, Eni is considered one of the global oil and gas super majors. Despite being a super major, Eni has had a difficult time since the start of the oil crash. However, the company’s impressive assets compared with the company’s respectable dividend yield make the company, as we will....More>>>
CEO of Medley Capital Corp (NYSE:MCC) Brook Taube bought 584,901 shares of MCC on 06/07/2017 at an average price of $6.08 a share. The total cost of this purchase was $3.6 million.
Medley Capital Corp is a non-diversified closed end management investment company in US. Its objective is to generate current income and capital appreciation by lending directly to privately held middle market....More>>>
New York, NY, based Investment company Saba Capital Management, L.P. buys Allergan PLC, Alpine Total Dynamic Dividend Fund, , First Trust Highome Long/Short Fund, Clough Global Equity Fund, Clough Global Dividend andome Fund, Clough Global Opportunities Fund, Community Health Systems, Delaware Enhanced Global Dividend of Beneficial In, Valeant Pharmaceuticals International, sells Blackrock Debt....More>>>
Six notable dividend stocks increased their payouts over the last week, including a global package delivery business, a railroad operator, and a manufacturer of glass for smartphones.
Stock markets around the world tumbled last week. Fears of rising inflation and higher interest rates seemed to be the biggest culprits behind the drop. While stock prices were generally falling, a number of....More>>>
As I said in a recent piece on PRA Health Sciences (NASDAQ:PRAH), there's a lot to like about the contract research organization (or CRO) sector as trial complexity increases, R&D budgets continue to grow, and drug companies look to shift toward their specialties and more variable-expense mod
Wall Street analysts expect Core-Mark (NASDAQ:CORE) to post earnings of $0.27 per share for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for Core-Mark’s earnings. The highest EPS estimate is $0.29 and the lowest is $0.24. Core-Mark posted earnings per sh
Gene-based therapy is one of the next waves of therapeutic innovation to power this decade and far beyond. The FDA approvals regarding the RNA-based medicines of Sarepta Therapeutics (NASDAQ:SRPT) and the gene-therapy, Luxturna, of Spark Therapeutics (NASDAQ:ONCE) signaled the lowered r